Effective segmentation of cervical cancer tissue from magnetic resonance (MR) images is crucial for automatic detection, staging, and treatment planning of cervical cancer. This study develops an innovative deep learning model to enhance the automatic segmentation of cervical cancer lesions. We obtained 4063 T2WI small-field sagittal, coronal, and oblique axial images from 222 patients with pathologically confirmed cervical cancer. Using this dataset, we employed a convolutional neural network (CNN) along with TransUnet models for segmentation training and evaluation of cervical cancer tissues. In this approach, CNNs are leveraged to extract local information from MR images, whereas Transformers capture long-range dependencies related to shape and structural information, which are critical for precise segmentation. Furthermore, we developed three distinct segmentation models based on coronal, axial, and sagittal T2WI within a small field of view using multidirectional MRI techniques. The dice similarity coefficient (DSC) and mean Hausdorff distance (AHD) were used to assess the performance of the models in terms of segmentation accuracy. The average DSC and AHD values obtained using the TransUnet model were 0.7628 and 0.8687, respectively, surpassing those obtained using the U-Net model by margins of 0.0033 and 0.3479, respectively. The proposed TransUnet segmentation model significantly enhances the accuracy of cervical cancer tissue delineation compared to alternative models, demonstrating superior performance in overall segmentation efficacy. This methodology can improve clinical diagnostic efficiency as an automated image analysis tool tailored for cervical cancer diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10278-025-01464-z | DOI Listing |
JAMA Netw Open
March 2025
Brigham and Women's Hospital, Boston, Massachusetts.
JAMA Netw Open
March 2025
Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Importance: Cervical screening guidelines in the US recommend that most females can exit routine screening at age 65 years following 2 recent consecutive negative cotest results (concurrent human papillomavirus and cytology tests). However, empirical data on the subsequent risks of cancer and cancer death in this subgroup of females are limited.
Objective: To estimate the risks of cervical cancer and cervical cancer death among females who meet the cotesting criteria to exit screening.
Cells
February 2025
Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833401, Taiwan.
Radioresistance remains a major obstacle in cervical cancer treatment, frequently engendering tumor relapse and metastasis. However, the details of its mechanism of action remain largely enigmatic. This study delineates the prospective impacts of short-form human T-cell lymphoma invasion and metastasis 2 (TIAM2S) involving the radiation resistance of cervical cancer.
View Article and Find Full Text PDFJ Otolaryngol Head Neck Surg
March 2025
Department of Otolaryngology, Jackson Memorial Hospital, Miami, FL, USA.
ImportanceSelective, modified radical, and radical neck dissections are common surgical procedures that can result in significant musculoskeletal issues of the neck and shoulder. Quality-of-life evaluations after neck dissection must assess and quantify these dysfunctions to allow subsequent comparison of outcomes after different treatments.ObjectiveThere is no validated Spanish-language questionnaire designed to evaluate neck and shoulder dysfunction after cervical lymphadenectomy.
View Article and Find Full Text PDFJ Med Virol
March 2025
Biosensors Laboratory, Department of Biomedical Engineering, Faculty of Engineering, Mahidol University, Nakhon Pathom, Thailand.
Human papillomavirus type 16 (HPV-16) is a key driver in the development of cervical carcinoma, with the integration of its genome into the host DNA marking a critical step in disease progression. Monitoring the physical state of HPV-16, particularly the transition from episomal to integrated forms, is essential for evaluating the risk of malignancy development in cervix. This study presents the development of a duplex electrochemical biosensor for the simultaneous detection of the E2 and E6 genes of HPV-16.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!